Article

We aimed to develop a goal classification of individualised goals for
spasticity treatment incorporating botulinum toxin intervention for upper limb
spasticity to under-pin a more structured approach to future goal setting.
DESIGN: Individualised goals for spasticity treatment incorporating botulinum
toxin intervention for upper limb spasticity (n=696) were analysed initially from
four studies published in 2008-2012, spanning a total of 18 centres (12 in the UK
and 6 in Australia). Goals were categorised and mapped onto the closest matching
domains of the WHO International Classification of Functioning. Confirmatory
analysis included a further 927 goals from a large international cohort study
spanning 22 countries published in 2013. RESULTS: Goal categories could be
assigned into two domains, each subdivided into three key goal areas: Domain 1:
symptoms/impairment n=322 (46%): a. pain/discomfort n=78 (11%), b. involuntary
movements n=75 (11%), c. range of movement/contracture prevention n=162 (23%).
Domain 2: Activities/function
n=374 (54%): a. passive function (ease of caring
for the affected limb) n=242 (35%), b active function (using the affected limb in
active tasks) n=84 (12%), c. mobility n=11 (2%).
Over 99% of the goals from the
large international cohort fell into the same six areas, confirming the
international applicability of the classification.
CONCLUSIONS: Goals for
management of upper limb spasticity, in worldwide clinical practice, fall into
six main goal areas.
CI - (c) The Author(s) 2015.

Langue : ANGLAIS